Page results
-
Sarcoma treatment is often extensive and can impact on a person’s ability to continue in work or return to work. While some people can continue working throughout their cancer treatment, others…
-
Achilles Therapeutics, a company built on research at UCLH, UCL Cancer Institute and the Francis Crick Institute has successfully raised $175.5 million through its initial public offering in the United States.
-
Des Haughton: Dr Russell Portrait Commission A portrait of Dr James Samuel Risien Russell, one of Britain’s first Black British consultants, was unveiled at the National Hospital for…
-
Support the Bring the Colour appeal and brighten up the children’s emergency department at University College Hospital.
-
A UCLH patient has received an innovative treatment for radiotherapy-induced dry mouth, an irreversible serious adverse effect of head and neck cancer radiotherapy that causes permanent impairment of talking and eating.
-
Welcome to the new London Sarcoma Service website, we hope that you can easily find the information that you need. We would be very grateful if you could speare a few minutes to give us some…
-
Whatever the treatment, test or intervention that is planned as part of the clinical trial the details will be explained both in the written information you receive and by your research nurse or…
-
Following the hottest summer on record in the capital, University College London Hospitals NHS Foundation Trust (UCLH) has launched ‘Critical Care For Our Climate’. The new strategy aims…
-
The trial results are good news for non-small cell lung cancer patients who are not eligible for standard of care platinum-based chemotherapy.
